Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehisa Kitano

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironmentToru Hanamura, Kozue Yokoyama, Shigehisa Kitano, et al.
Investigational New Drugs|August 22, 2025
Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumorsIppei Miyamoto, Takahiro Kogawa, Kana Kurokawa, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2022
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumorsShigehisa Kitano, Yutaka Fujiwara, Toshio Shimizu, et al.
Cancer Immunology Research|December 25, 2019
CD4<sup>+</sup> T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 TherapyHiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi, et al.
Investigational New Drugs|June 12, 2021
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I studyAkira Kawai, Norifumi Naka, Akihiko Shimomura, et al.
British Journal of Cancer|November 16, 2021
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy settingDaiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, et al.
Cancer Genetics and Cytogenetics|June 19, 2008
Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0Atsushi Fujieda, Masahiro Masuya, Shigehisa Kitano, et al.
Histopathology|November 29, 2020
Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterationsTakuo Hayashi, Shinji Kohsaka, Kazuya Takamochi, et al.
Cancer Research|October 11, 2022
Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade EfficacyHiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2025
Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinomaShoko Sonobe Shimamura, Takehito Shukuya, Makiko Yamashita, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironmentToru Hanamura, Kozue Yokoyama, Shigehisa Kitano, et al.
Investigational New Drugs|August 22, 2025
Clinical potential of antibody-drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumorsIppei Miyamoto, Takahiro Kogawa, Kana Kurokawa, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2022
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumorsShigehisa Kitano, Yutaka Fujiwara, Toshio Shimizu, et al.
Cancer Immunology Research|December 25, 2019
CD4<sup>+</sup> T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 TherapyHiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi, et al.
Investigational New Drugs|June 12, 2021
Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I studyAkira Kawai, Norifumi Naka, Akihiko Shimomura, et al.
British Journal of Cancer|November 16, 2021
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy settingDaiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, et al.
Cancer Genetics and Cytogenetics|June 19, 2008
Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0Atsushi Fujieda, Masahiro Masuya, Shigehisa Kitano, et al.
Histopathology|November 29, 2020
Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterationsTakuo Hayashi, Shinji Kohsaka, Kazuya Takamochi, et al.
Cancer Research|October 11, 2022
Single-Cell Analysis Reveals a CD4+ T-cell Cluster That Correlates with PD-1 Blockade EfficacyHiroshi Kagamu, Satoshi Yamasaki, Shigehisa Kitano, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2025
Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinomaShoko Sonobe Shimamura, Takehito Shukuya, Makiko Yamashita, et al.
Pageof 15